In the News


Clinical practice guideline presents multidisciplinary approach to diabetes foot care

The guideline addresses prevention of diabetic foot ulceration, off-loading of diabetic foot ulcers, diagnosis of osteomyelitis, wound care, and peripheral arterial disease.

Insulin/liraglutide combination effective in uncontrolled diabetes, study finds

Combination insulin degludec and liraglutide was noninferior to up-titration of glargine at reducing HbA1c in patients with uncontrolled type 2 diabetes in an industry-funded phase III trial.

Results appear similar at 2 years for diabetic macular edema drugs

Eyes were assigned to receive 2.0 mg aflibercept, 1.25 mg repackaged (compounded) bevacizumab, or 0.3 mg ranibizumab. Intravitreous injections were administered up to once per month according to a follow-up and retreatment regimen specified by protocol.

MKSAP quiz: Diabetes testing

This month's quiz asks readers about the appropriate diagnostic testing for diabetes mellitus in an asymptomatic 55-year-old man.

Synopsis of ADA standards and new Graphic Medicine feature

The synopsis by diabetes experts was written specifically for primary care physicians and summarized the ADA Standards of Medical Care in Diabetes into 8 areas of importance.

In abstinent adults with type 2 diabetes, a daily glass of wine (vs mineral water) improved cardiometabolic factors

Drinking red wine, rather than mineral water, with dinner every night for 2 years was associated with improvements in cholesterol markers in patients in Israel. A group assigned to white wine did not show significant differences on these markers from the water group.

Antihypertensives associated with worse outcomes in diabetic patients with lower SBP

Blood pressure treatment goals should be less aggressive in people with diabetes than without diabetes, study authors said, because if systolic blood pressure (SBP) is already less than 140 mm Hg, additional agents might be harmful.

Test strips recalled

The SPOTCHEM II Basic PANEL-1 Reagent Test Strip and SPOTCHEM II Glucose Reagent Test Strip may report falsely low blood glucose levels.

Spotlight on potential risks of DPP-4 inhibitors

Recent studies examined potential associations of the drugs with heart failure, pancreatic cancer, and fractures.

Physician editor: David V. O'Dell, MD, FACP